13D Filing: Waud Capital Partners Ii, L.p. and Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 1 of 27

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Waud Capital Partners II 0 570,710 0 570,710 570,710 0.7%
Waud Capital Partners QP II 0 1,043,348 0 1,043,348 1,043,348 1.2%
Halcyon Exempt Family Trust 0 531,113 0 531,113 531,113 0.6%
Waud Family Partners 0 41,765 0 41,765 41,765 0.05%
WCP FIF II (Acadia) 0 159,233 0 159,233 159,233 0.2%
Waud Capital Affiliates II 0 163,082 0 163,082 163,082 0.2%
Waud Capital Affiliates III 0 83,694 0 83,694 83,694 0.1%
WCP FIF III (Acadia) 0 227,335 0 227,335 227,335 0.3%
Waud Capital Partners QP III 0 518,000 0 518,000 518,000 0.6%
Waud Capital Partners III 0 91,602 0 91,602 91,602 0.1%
Waud Capital Partners Management II 0 1,936,373 0 1,936,373 1,936,373 2.2%
Waud Capital Partners II 0 1,936,373 0 1,936,373 1,936,373 2.2%
Waud Capital Partners Management III 0 920,631 0 920,631 920,631 1.1%
Waud Capital Partners III 0 920,631 0 920,631 920,631 1.1%
Waud Capital Partners 0 39,851 0 39,851 39,851 0.05%
Crystal Cove 0 795,667 0 795,667 795,667 0.9%
Reeve B. Waud 0 4,298,733 0 4,298,733 4,298,733 4.9%
Melissa W. Waud 0 33,333 0 33,333 33,333 0.04%

Page 1 of 27 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE
13D/A

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(a)

Under the Securities Exchange Act of 1934

(Amendment No. 5)

Acadia
Healthcare Company, Inc.

(Name of issuer)

Common Stock,
par value $0.01

(Title of class of securities)

00404A109

(CUSIP number)

Waud Capital Partners

300 N. LaSalle St., Suite 4900

Chicago, IL 60654

(312)
676-8400

COPY TO:

Carol
Anne Huff

Kirkland & Ellis LLP

300 N. LaSalle St.

Chicago, Illinois 60654

(312) 862-2000

(Name,
Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 15,
2017

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ☐

Note: Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)














Page 1 of 27